For instance, EZH2’s dual role in suppressing tumor suppressor genes (e.g., CDKN1A, NLRP3) while activating pro-survival signals (e.g., Snail/EGFR) highlights its adaptability as a molecular switch in resistance trajectories. This evidence concerns the gene CDKN1A and neoplasm.